Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1808015
DOI: 10.1055/s-0045-1808015
THORACIC TUMORS
1814
POSTER PRESENTATION
Prognostic significance of hemoglobin and hematocrit levels in non-small cell lung cancer treated with immune checkpoint inhibitors
Authors
Keywords
non-small cell lung cancer - immune checkpoint inhibitors - complete blood count - immunotherapy - biomarkersPublication History
Article published online:
06 May 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Katiane Tostes, Tauana Christina Dias, Gabriela Karam Rebolho, Gabriela Panini Batagelo, Isabela Fernandes Rivelli Cardoso, Flávio Augusto Ferreira da Silva, Pedro Rafael Martins De Marchi, Celine Marques Pinheiro, Letícia Ferro Leal, Lidia Maria Rebolho Batista Arantes. Prognostic significance of hemoglobin and hematocrit levels in non-small cell lung cancer treated with immune checkpoint inhibitors. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1808015
Katiane Tostes, Tauana Christina Dias, Gabriela Karam Rebolho, Gabriela Panini Batagelo, Isabela Fernandes Rivelli Cardoso, Flávio Augusto Ferreira da Silva, Pedro Rafael Martins De Marchi, Celine Marques Pinheiro, Letícia Ferro Leal, Lidia Maria Rebolho Batista Arantes. Prognostic significance of hemoglobin and hematocrit levels in non-small cell lung cancer treated with immune checkpoint inhibitors. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1808015